SCHEMBL2175349

SCHEMBL2175349

Cc1nc2nc(S)nc(O)c2nc1C

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12787829 0.77 NQO2 (0.33) NQO2
SCHEMBL2492490 0.74 MAPT (0.35) NQO2
SCHEMBL12261745 0.74 MAPT (0.31)
SCHEMBL13596901 0.72 ALDH1A1 (0.35)
SCHEMBL12479350 0.68
SCHEMBL7037128 0.67
SCHEMBL9679869 0.65 ADORA2A (0.38)
SCHEMBL2494141 0.64 PIK3CG (0.33)
SCHEMBL3831629 0.63
SCHEMBL11683953 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011082098-A1 LYSINE AND ARGININE METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER THE ROCKEFELLER UNIVERSITY (US) 2011-07-07 WO disclosed